SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently experiencing intense market volatility and significant short-squeeze momentum as investors anticipate the final phase 3 data from its REGAL trial for acute myeloid leukemia. The community is actively debating the significance of the extended trial timeline and the potential for a major buyout, with many long-term shareholders holding firm in anticipation of a transformative valuation event.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending after the announcement of its divestiture of Del Taco, a move aimed at streamlining operations and reducing debt levels. Community sentiment is deeply polarized, with some investors betting on a potential short squeeze due to high short interest and a low float, while others express concerns over the company's significant debt load and the strategic loss taken on the Del Taco sale.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently facing intense selling pressure and negative sentiment as investors express frustration over a prolonged stock decline, weak price action during broader market rallies, and a perceived lack of meaningful catalysts from management during industry events. The community is deeply divided, with some investors betting on a long-term turnaround based on strong fundamentals and insider buying, while others are actively shorting the stock, citing management failures, market rotation out of software, and the lack of concrete new revenue deals to spark momentum.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending due to the company's major strategic announcement to spin off its media assetsincluding NBCUniversal and Skyinto a separate public company, a move investors are weighing as a potential catalyst to unlock long-term shareholder value. The community is actively debating the implications of this separation, with many focused on whether this leaner structure will revitalize the stock or if persistent concerns about the media landscape and cable cord-cutting will continue to weigh on market sentiment.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the company moves to discontinue internal discovery programs and close its Alabama research facility, a strategic pivot that community members are interpreting as potential preparation for a long-rumored buyout. While some investors view the cost-cutting as a necessary move to boost profitability and streamline the business for acquisition, others express frustration over the company's long-term stagnant performance and history of leadership challenges.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis stock is facing heavy downward pressure after announcing a massive 22-billion-euro business reset and restructuring charge that triggered a suspension of its 2026 dividend. Investors are actively debating the company's long-term viability, with many questioning the shift away from ambitious EV plans while others see a potential deep-value turnaround play after the reset is fully realized.

Cantor Equity Partners II, Inc. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Cantor Equity Partners II is gaining attention as it nears its business combination with Securitize, with shareholders actively discussing the company's emergence as a regulated infrastructure leader for tokenized real-world assets. Community sentiment is largely focused on the upcoming ticker change to SECZ and the significant institutional backing from major financial players that reinforces the long-term potential of the tokenization sector.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors react to a newly announced bitcoin monetization program, which allows the company to sell holdings to fund share repurchases and stabilize its capital structure. Community sentiment is deeply divided, with bulls viewing the shift as a necessary and accretive strategic evolution, while skeptics warn it signals long-term instability and a departure from the company's core bitcoin accumulation thesis.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is facing significant selling pressure as investors react to management's revised growth outlook for its Watchman product line, driving the stock to fresh yearly lows. While the community is debating whether this decline represents a major buying opportunity or a deeper value trap, many are pointing to the company's aggressive share repurchase program as a potential support level for a future recovery.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is facing significant downward pressure and intense community debate following a negative short-seller report that raised questions about manufacturing operations and order validity. While investors remain divided, the stock is seeing high volatility as retail traders weigh the impact of these allegations against the company's long-term growth narrative in the drone and advanced battery sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innovator ETFs Trust - Innovator U.S. Equity Accelerated 9 Buffer ETF - April

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

XBAPInnovator ETFs Trust - Innovator U.S. Equity Accelerated 9 Buffer ETF - April

Latest XBAP News